Cost of AF Ablation : Where Do We Stand?

Abstract EN

Atrial fibrillation (AF) is a common and frequently disabling chronic condition associated with significant patient morbidity and affecting an increasing stratum of our ageing society.

Direct costs related to atrial fibrillation are comprised from direct cost of medical therapy, catheter ablation, and related hospitalizations and imaging procedures, with indirect costs related to complications of the primary therapeutic strategy, management of related conditions, as well as disability and loss in quality of life related to AF.

Over the last decade, catheter ablation became a promising alternative to rate and rhythm control among symptomatic AF patients.

The purpose of this paper is to describe the evidence on the financial implications related to ablation based on published data and authors' experience.